Radioimmunoassay of serum medroxyprogesterone acetate (Provera ®) in women following oral and intravaginal administration

@article{Hiroi1975RadioimmunoassayOS,
  title={Radioimmunoassay of serum medroxyprogesterone acetate (Provera {\textregistered}) in women following oral and intravaginal administration},
  author={M. Hiroi and F. Stanczyk and U. Goebelsmann and P. Brenner and M. Lumkin and D. Mishell},
  journal={Steroids},
  year={1975},
  volume={26},
  pages={373-386}
}
A radioimmunoassay (RIA) method for measuring medroxyprogesterone acetate (MPA, Provera) in serum has been developed utilizing benzene:iso-octane extraction, 3H-MPA to assess procedural losses, goat anti-MPA-3-(0-carboxymethyl) oxime-bovine serum albumin serum and dextran-coated charcoal separation. Control serum blanks were undetectable, 200 pg/ml of MPA was measurable with a high reliability, and intra- and interassay coefficients of variation were 6 and 13 percent, respectively. MPA added to… Expand
A radioimmunoassay for serum medroxyprogesterone acetate.
Homologous ELISA for measurement of medroxyprogesterone acetate in serum.
Enzyme immunoassay for nomegestrol acetate in human plasma
...
1
2
3
4
5
...

References

SHOWING 1-8 OF 8 REFERENCES